 LAVAL, QC and CAMBRIDGE, England, July 22, 2020 CNW Telbec - Liminal BioSciences Inc. NASDAQ: LMNL TSX: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company, announces that it has applied for a voluntarily delisting of its common shares Common Shares from the Toronto Stock Exchange TSX in Canada. Subject to such application being accepted by the TSX, it is expected that the Common Shares will be delisted from the TSX effective as of the close of trading on August 5, 2020. 